Ad5-nCoV Completed Phase 1 Trials for Coronavirus Disease 2019 (COVID‑19) Prevention

IndicationsStatusPurposePhase
CompletedPrevention1
clinicaltrials.gov IdentifierTitleDrugs
NCT04313127Phase I Clinical Trial of a COVID-19 Vaccine in 18-60 Healthy Adults